Latest Headlines

  1. CellCarta Adds Tempus To CDx Commercialization Lab Network 8/6/2026

    CellCarta, a global CRO laboratory supporting the biopharmaceutical industry, today announced a strategic collaboration with Tempus AI, Inc. Under the agreement, CellCarta will include Tempus in its CDx Commercialization Lab Network as the network’s second commercial laboratory partner, strengthening oncology-focused companion diagnostics offerings to biopharma sponsors.

  2. ECU Health Microbiology Lab Launches bioMérieux VITEK REVEAL Analyzer 8/5/2026

    ECU Health Medical Center is the fifth institution in the nation to begin using the bioMérieux VITEK REVEAL analyzer, a rapid blood culture testing tool that can help providers identify effective antibiotics for certain bloodstream infections approximately 24 hours sooner than standard methods.

  3. Eastern Caribbean Countries Strengthen Molecular Diagnostic Capacity To Enhance Preparedness For Emerging Infectious Diseases 8/5/2026

    Laboratory professionals from across the Eastern Caribbean have enhanced their capacity to rapidly detect and respond to infectious diseases with epidemic and pandemic potential following a regional workshop on molecular diagnostics hosted by the Pan American Health Organization/World Health Organization (PAHO/WHO), in collaboration with the Caribbean Public Health Agency (CARPHA) and the Best-dos Santos Public Health Laboratory, a PAHO/WHO Collaborating Centre on Antimicrobial Resistance Surveillance.

  4. Leeds NHS Innovation To Accelerate Global Adoption Of AI-Enabled Pathology For Cancer Diagnostics Through Epredia Partnership 8/5/2026

    A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision cancer diagnostics solutions. NHS is the UK's National Health Service.

  5. LabPMM Launches Global KMT2A MRD Testing Service To Support Menin Inhibitor Development And Acute Leukemia Care 8/4/2026

    LabPMM, an Invivoscribe subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.

  6. SOPHiA GENETICS Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies 8/4/2026

    SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN).

  7. Ferris State's College Of Pharmacy And College Of Engineering Tech Collaborate To Fulfill Lab Equipment Needs, Help Solve Practical Problems 8/3/2026

    Ferris State University is embodying campus collaboration as the College of Pharmacy and the College of Engineering Technology found a solution to laboratory equipment needs.

  8. Cizzle Bio Expands Access To Early Lung Cancer Detection Through Strategic Laboratory Collaboration With BioBridge Global In South Texas 8/3/2026

    Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, today announced that it has executed a strategic laboratory agreement with BioBridge Global (BBG), a San Antonio-based healthcare services organization with expertise in laboratory medicine, biomanufacturing, blood banking and translational science.

  9. Laboratory Basics For High-Consequence Infectious Diseases: Safe Testing Starts With Preparation 8/3/2026

    When caring for patients with suspected high-consequence infectious diseases (HCIDs) such as Ebola, Lassa fever, Marburg virus disease, or Middle East respiratory syndrome (MERS), timely laboratory testing is essential—but it must also be performed safely. 

  10. GenomOncology Announces Integrated End-To-End Workflow Using Pacbio's Long-Read Whole-Genome Sequencing Technology In Oncology 7/30/2026

    GenomOncology (GO), a precision oncology software company specializing in genomic data interpretation and reporting, today announced an end-to-end workflow for somatic whole-genome sequencing (WGS) in oncology.